Controls | IgAN without progression | IgAN with progression | |
---|---|---|---|
N | 15 | 16 | 9 |
Year of diagnosis | 2000 ± 7.7 | 1996 ± 3.4 | 1998 ± 5.7 |
Proportion female | 53.3% | 12.5% | 33.3% |
Age (years) | 32.0 ± 11.9 | 31.4 ± 13.4 | 31.2 ± 15.8 |
Serum creatinine (μmol/l) | 79.3 ± 20.9 | 91.5 ± 21.5 | 105.8 ± 25.6* |
Estimated glomerular filtration ratea (ml/min/1.73 m2) | 113.13 ± 18.5 | 114.19 ± 25.3 | 91.89 ± 26.3* |
Systolic blood pressure (mmHg) | 118.6 ± 14.6 | 127.2 ± 14.3 | 135.4 ± 25.8 |
Diastolic blood pressure (mmHg) | 77.6 ± 8.4 | 78.9 ± 11.6 | 78.8 ± 13.1 |
Urinary protein (g/24 h) | 0.16 ± 0.17 | 1.76 ± 1* | 2.00 ± 1.98* |
Body weight (kg) | 74.7 ± 11.9 | 76.1 ± 8.0 | 75.4 ± 12.5 |
No of years of follow-up | 12.3 ± 7.7 | 16.3 ± 3.4 | |
No of years from biopsy to ESRD | 5.8 ± 2.5 | ||
Percentage with M-score of 1 | Not applicable | 31.3% | 44.4% |
Percentage with E-score of 1 | Not applicable | 31.3% | 33.3% |
Percentage with S-score of 1 | Not applicable | 50% | 77.8% |
Percentage with T-score of 1 or 2 | Not applicable | 0% | 44.4%* |